Overview
Myelin Therapeutics is a clinical-stage biotech developing gene therapies targeting myelin repair and remyelination for patients with multiple sclerosis and related demyelinating diseases.
More in Neuropharmaceuticals
Latest industry news
Flourish Emerges From Stealth With Bezos and Google Ventures Backing to Tackle Neuroscience
2026-10-26 · Funding
FDA Grants De Novo Approval to Modius Spero Neuromodulation Device for PTSD
2026-10-25 · Product
Wearable Neurofeedback Startup BRYM Secures €650K to Build Next-Generation Brain Training Platform
2026-10-24 · Funding
Brain-Computer Interface Gives Unresponsive ICU Patients Auditory Control for the First Time
2026-10-23 · Research
Company details
Category
💊 Neuropharmaceuticals
Location
Cambridge, MA
Funding
Series A — $28M
Website
myelintherapeutics.comListed
2026-10-26
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →